Clinical significance of expression of Hint1 and potential epigenetic mechanism in gastric cancer

International Journal of Oncology

Volumn 38, Issue 6, 2011, Pages 1557-1564

  Huang, Huaying ^a   Wei, Xiaowei ^a   Su, Xianwei ^b   Qiao, Fengchang ^b   Xu, Zhi ^a   Gu, Dongying ^a   Fan, Hong ^b   Chen, Jinfei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

EB virus; GC; H. pylori; Hint1; Promoter methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; HINT1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL LINE, TUMOR; EPIGENESIS, GENETIC; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HEP G2 CELLS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; STOMACH NEOPLASMS;

EID: 79955833988     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.994     Document Type: Article

References (46)

1. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1: 10-24, 1998.
2. Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K and Ushijima T: The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int J Cancer 124: 905-910, 2009.
3. Uozaki H and Fukayama M: Epstein-Barr virus and gastric carcinoma - viral carcinogenesis through epigenetic mechanisms. Int J Clin Exp Pathol 1: 198-216, 2008.
4. Brenner C: Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases. Biochemistry 41: 9003-9014, 2002.
5. Su T, Suzui M, Wang L, Lin CS, Xing WQ and Weinstein IB: Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci USA 100: 7824-7829, 2003. (Pubitemid 36760054)
6. Li H, Zhang Y, Su T, Santella RM and Weinstein IB: Hint1 is a haploinsufficient tumor suppressor in mice. Oncogene 25: 713-721, 2006. (Pubitemid 43214698)
7. Weiske J and Huber O: The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity. J Biol Chem 281: 27356-27366, 2006. (Pubitemid 44401763)
8. SKP2 ubiquitin ligase and Src. J Biol Chem 284: 5265-5276, 2009.
9. Weiske J and Huber O: The histidine triad protein 1 interacts with Pontin and Reptin and inhibits TCF-β-catenin-mediated transcription. J Cell Sci 118: 3117-3129, 2005. (Pubitemid 41149915)
10. Razin E, Zhang ZC, Nechushtan H, Frenkel S, Lee YN, Arudchandran R and Rivera J: Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J Biol Chem 274: 34272-34276, 1999. (Pubitemid 129511768)
11. Lee YN and Razin E: Nonconventional involvement of LysRS in the molecular mechanism of USF2 transcriptional activity in FceRI-activated mast cells. Mol Cell Biol 25: 8904-8912, 2005.
12. Wang L, Zhang Y, Li H, Xu Z, Santella RM and Weinstein IB: Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res 67: 4700-4708, 2007. (Pubitemid 46910176)
13. Brzoska PM, Chen H, Zhu Y, et al: The product of the ataxia- telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc Natl Acad Sci USA 92: 7824-7828, 1995.
14. Ajit SK, Ramineni S, Edris W, Hunt RA, Hum WT, Hepler JR and Young KH: RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. Cell Signal 19: 723-730, 2007. (Pubitemid 46275365)
15. Guang W, Wang H, Su T, Weinstein IB and Wang JB: A novel μ-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol Pharmacol 66: 1285-1292, 2004. (Pubitemid 39411068)
16. Zhang YJ, Li H, Wu HC, et al: Silencing of Hint1, a novel tumor suppressor gene, by promoter hypermethylation in hepatocellular carcinoma. Cancer Lett 275: 277-284, 2009.
17. Yuan BZ, Jefferson AM, Popescu NC and Reynolds SH: Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2′-deoxycytidine. Neoplasia 6: 412-419, 2004. (Pubitemid 38924856)
18. Tamura G, Yin J, Wang S, et al: E-cadherin gene promoter hypermethylation in primarv human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000.
19. Fleisher AS, Esteller M and Wang S: Hypemethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59: 1090-1095, 1999.
20. Fleisher AS, Esteller M, Tamura G, et al: Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 20: 329-335, 2001.
21. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y and Imai K: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313, 1999. (Pubitemid 29455752)
22. Toyota M, Ahuja N, Suzuki H, et al: Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59: 5438-5442, 1999. (Pubitemid 29526452)
23. Endoh Y, Tamura G, Ajioka Y, Watanabe H and Motoyama T: Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 157: 717-722, 2000.
24. Tamura G, Sato K, Akiyama S, et al: Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 81: 593-598, 2001. (Pubitemid 32298805)
25. Tsuchiya T, Tamura G, Sato K, et al: Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19: 3642-3646, 2000.
26. Byun DS, Lee MG, Chae KS, Ryu BG and Chi SG: Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 61: 7034-7038, 2001.
27. Leung WK, Yu J, Ng EK, et al: Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 91: 2294-2301, 2001. (Pubitemid 32552815)
28. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG: CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 61: 2847-2851, 2001. (Pubitemid 32691923)
29. Kang GH, Lee S, Kim WH, Lee HW, Kim JC, Rhyu MG and Ro JY: Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160: 787-794, 2002. (Pubitemid 34224568)
30. Sato K, Tamura G, Tsuchiya T, Endoh Y, Usuba O, Kimura W and Motoyama T: Frequent loss of expression without sequence mutations in the DCC gene in gastric cancer. Br J Cancer 85: 199-203, 2001.
31. Sato K, Tamura G, Tsuchiya T, et al: Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch 440: 160-165, 2002.
32. Honda T, Tamura G, Waki T, et al: Hypermethylation of TSLC1 gene promoter in gastric cancer. Jpn J Cancer Res 93: 857-860, 2002.
33. Lee TL, Leung WK, Chan MW, et al: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002. (Pubitemid 34633732)
34. Li QL, Ito K and Sakakura C: Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124, 2002.
35. Sakata K, Tamura G, Endoh Y, Ohmura K, Ogata S and Motoyama T: Hypermethylation of hMLH1 promoter in solitary and multiple gastric cancers with microsatellite instability. Br J Cancer 86: 564-567, 2002.
36. Satoh A, Toyota M, Itoh F, et al: DNA methylation and histone deacetylation associated with silencing DAP-kinase gene expression in colorectal and gastric cancers. Br J Cancer 86: 1817-1823, 2002.
37. To KF, Leung WK, Lee TL, et al: Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer. Int J Cancer 102: 623-628, 2002. (Pubitemid 35334471)
38. Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S and Motoyama T: Promoter methylation status of E-cadherin, hMLH1 and p16 genes in non-neoplastic gastric epithelia. Am J Pathol 161: 399-403, 2002.
39. Waki T, Tamura G, Sato M, Terashima M, Nishizuka S and Motoyama T: Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci 94: 360-364, 2003.
40. Nakase Y, Sakakura C and Miyagawa K: Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Br J Cancer 92: 562-569, 2005.
41. Honda T, Tamura G, Waki T, Kawata S, Nishizuka S and Motoyama T: Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia. Br J Cancer 90: 2013-2016, 2004.
42. Obata T, Toyota M, Satoh A, et al: Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. Clin Cancer Res 9: 6410-6418, 2003. (Pubitemid 38031827)
43. Kaneda A, Wakazono K, Tsukamoto T, et al: Lysyl oxidase is a tumor suppressor gene inactivated by rnethvlation and loss of heterozvgosity in human gastric cancers. Cancer Res 64: 6410-6415, 2004. (Pubitemid 39297894)
44. Wang L, Li H, Zhang Y, Santella RM and Weinstein IB: Hint1 inhibits β-catenin/TCF4, USF2 and NFκB activity in human hepatoma cells. Int J Cancer 124: 1526-1534, 2009.
45. Li H, Balajee AS, Su T, Cen B, Hei TK and Weinstein IB: The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage. J Cell Biol 183: 253-265, 2008.
46. Choi EK, Rhee YH, Park HJ, Ahn SD, Shin KH and Park KK: Effect of protein kinase C inhibitor (PKCI) on radiation sensitivity and c-fos transcription. Int J Radiat Oncol Biol Phys 49: 397-405, 2001. (Pubitemid 32120236)